Shamir Celebrates Five Decades of Ophthalmic Innovation

By Staff
Thursday, May 26, 2022 12:30 AM KIBBUTZ SHAMIR, Israel—Shamir Optical Industry brought management, employees and business partners from around the world to its corporate headquarters and R&D center here for a joyous 50th anniversary celebration this week.

MacuLogix Moves to Wind Down Operations as a 'Going Concern,' as Liquidity Issues Become Insurmountable

By Staff
Wednesday, May 25, 2022 12:30 AM MIDDLETOWN, Pa.—MacuLogix Inc., a company founded a decade ago to support ECPs with the tools and resources needed to diagnose and monitor patients with age-related macular degeneration (AMD), is winding down operations and has assigned its assets to a firm that specializes in working with creditors in business liquidation processes, according to a filing in the Delaware Court of Chancery late last week. This assignment of assets includes patent rights and related intellectual property. Maculogix, which conducted a months-long search for a buyer or new investors, owes approximately $23 million to secured creditors, according to the court filing.

CooperVision Appoints Alex Wilkes as President, Americas

By Staff
Tuesday, May 24, 2022 12:30 AM SAN RAMON, Calif.—CooperVision, one of the world’s leading manufacturers of contact lenses, has named Alex Wilkes as president, Americas, effective June 14. Wilkes brings more than a decade of experience in the eyecare industry, having most recently served as senior vice president and general manager of Pearle Vision at Luxottica Retail. At CooperVision, Wilkes will be responsible for the executive leadership and driving the growth of the company’s largest region, determining the strategic direction for the U.S., Canada and Latin America, according to Monday’s announcement.

Alcon to Acquire Eysuvis in a Move That Adds to Its Ophthalmic Eye Drop Portfolio

By Staff
Tuesday, May 24, 2022 12:27 AM GENEVA—Alcon (SIX/NYSE: ALC) said on Monday that it has signed an agreement to acquire Eysuvis (loteprednol etabonate suspension) 0.25% pharmaceutical eye drops from Kala Pharmaceuticals Inc.

CooperCompanies Releases 2021 Environmental, Social and Governance Highlights Report, Signs on to United Nations Global Compact

By Staff
Thursday, May 19, 2022 12:27 AM SAN RAMON, Calif.—CooperCompanies (NYSE: COO) has announced the publication of its 2021 Environmental, Social and Governance (ESG) Highlights Report, sharing the company’s progress on ESG items most important to its businesses and stakeholders, including employees, shareholders, customers and global communities.

DrChrono Receives 2022 MedTech Breakthrough Award for Work on Health Platform That Powered a COVID-19 Vaccination Project

By Staff
Thursday, May 19, 2022 12:18 AM SUNNYVALE, Calif.—DrChrono Inc., a platform for electronic health records and medical practices, has been selected as the winner of the “EHR Innovation” award in the sixth annual MedTech Breakthrough Awards program. DrChrono worked with CORE (Community Organized Relief Effort), an emergency relief non-profit organization co-founded by Sean Penn and Ann Lee, Curogram, a leading HIPAA-compliant patient communications tool and messaging platform, and the state of Georgia to operate mobile and fixed COVID-19 vaccine sites, with a goal to deliver vaccines to underserved patients throughout all 18 health districts in Georgia, according to the company’s recent announcement.

All U.S. Executives Spot Potential Risks in AI

By Staff
Wednesday, May 18, 2022 9:00 AM In the U.S., 56 percent of executives believe AI technology comes with either significant or somewhat significant potential risk. Another 19 percent view the risk as moderate, while 26 percent think the threat is minimal. No executive surveyed believes AI is entirely without risk.

Executives name cybersecurity as the No. 1 AI-related risk to their organization, but they may be missing the very real threat of algorithmic bias. Most U.S. companies use AI for hiring and people management, but 39 percent of executives said no one at their company is responsible for identifying implicit bias in the tech. 

Meanwhile, 38 percent report their corporate board isn’t fully aware of how the company uses AI, likely exacerbating blind spots about the risks involved.

Alcon Celebrates 75th Anniversary and Notes its History of Breakthrough Innovation in Eyecare

By Staff
Tuesday, May 17, 2022 12:24 AM GENEVA—On Monday, Alcon marked the company’s 75th anniversary with its “Brilliant History, Brilliant Future” celebration. On May 16, 1947, Alcon Laboratories Inc. was incorporated and began manufacturing specialty pharmaceutical products in Fort Worth, Texas, the company noted in its announcement.

Kits Reports Slight Sales Decline in First Quarter Total Revenue and Notes Large Growth in Eyeglasses Revenue

By Staff
Friday, May 13, 2022 12:24 AM VANCOUVER, Canada—Kits Eyecare Ltd. (TSX: KITS / OTCQX: KTYCF), a direct-to-consumer glasses manufacturer and digital eyecare provider, reported this week that its revenue in the first quarter dipped roughly 2 percent to $20.1 million.

Final Two Companies Reach a Settlement in Long-Running Contact Lens Price-Fixing Suit

By Staff
Friday, May 13, 2022 12:21 AM JACKSONVILLE, Fla.—Bringing a long-running price-fixing case closer to a conclusion, a federal judge in Florida this week gave preliminary approval to proposals from Alcon Vision LLC and Johnson & Johnson Vision Care that would settle their roles in the matter, according to a May 9 court filing.

Alcon Reports Double-Digit Sales Growth in Vision Care, Surgical in First Quarter

By Staff
Thursday, May 12, 2022 12:24 AM GENEVA—Calling its performance “a strong start to the year,” Alcon (SIX/NYSE:ALC) reported that worldwide sales increased 14 percent on a reported basis to $2.2 billion in its first quarter ended March 31.

Bausch Health Companies Inc. Announces ‘Stable’ First-Quarter 2022 Results

By Staff
Wednesday, May 11, 2022 12:21 AM LAVAL, Quebec—Bausch Health Companies Inc. (NYSE/TSX: BHC) yesterday reported $1.918 billion in total revenue for the first quarter of 2022, as compared to $2.027 billion in the first quarter of 2021, a decrease of $109 million, or 5 percent.

CooperVision Kicks Off 2022 Myopia Management Workshop Series

By Staff
Tuesday, May 10, 2022 12:21 AM SAN RAMON, Calif.—CooperVision, a global leader in myopia management, has kicked off its 2022 Myopia Management Workshop series. The immersive full-day events are designed to accelerate practices’ clinical and business success in the fast-growing sector.

Bausch + Lomb Completes Stock Offering and Becomes Independent Publicly Traded Company, Shares Rise on First Trading Day

By Staff
Monday, May 9, 2022 12:21 AM VAUGHAN, Ontario—At the end of a topsy-turvy week for the stock market, Bausch + Lomb Corp. (NYSE/TSX: BLCO) on Friday launched as an independent, publicly traded company when it began trading under the “BLCO” symbol on the New York Stock Exchange and Toronto Stock Exchange.

CooperVision Seeks Proposals for 2022 Science and Technology Awards

By Staff
Friday, May 6, 2022 12:15 AM SAN RAMON, Calif.—To promote continuous advancement in contact lens research and development, CooperVision is now accepting submissions for its 2022 Science and Technology Awards program.